Division of Infectious Diseases

September 18, 2014

State public health award named for Schaffner

The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.

By Craig Boerner
flu shot
August 13, 2014

High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.

By Craig Boerner
May 7, 2014

Eleven faculty honored with endowed chairs

Eleven Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration April 30 at the Student Life Center.

By Bill Snyder
May 1, 2014

Cutting-edge research to be showcased in May

By Bill Snyder
April 24, 2014

Schaffner honored by pharmacy association

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.

By Chanler Knowles
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

By Bill Snyder
January 23, 2014

Human and Helicobacter co-evolution

By VUMC News and Communications
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
By Leigh MacMillan
November 14, 2013

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.
By Jessica Pasley
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
By Leigh MacMillan
April 4, 2013

Vanderbilt researchers work to balance flu vaccine debate

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.
By VUMC News and Communications
March 14, 2013

New center to focus on treating, preventing TB

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.
By Bill Snyder
March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
By Nancy Humphrey
1 … 9 10 11 12 13